CVS Caremark Corporation  

(Public, NYSE:CVS)   Watch this stock  
Find more results for CVS
+0.02 (0.03%)
Aug 29 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 79.28 - 79.80
52 week 56.32 - 79.82
Open 79.50
Vol / Avg. 2.42M/3.64M
Mkt cap 92.01B
P/E 19.44
Div/yield 0.28/1.38
EPS 4.09
Shares 1.16B
Beta 0.97
Inst. own 86%
Nov 4, 2014
Q3 2014 CVS Caremark Corp Earnings Release - 9:30AM EST - Add to calendar
Sep 9, 2014
CVS Caremark Corp at Morgan Stanley Healthcare Conference - 8:35AM EDT - Add to calendar
Aug 5, 2014
Q2 2014 CVS Caremark Corporation Earnings Release
Aug 5, 2014
Q2 2014 CVS Caremark Corp Earnings Call
Jun 18, 2014
CVS Caremark Corp at Wells Fargo Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 3.60% 3.63%
Operating margin 6.38% 6.34%
EBITD margin - 7.83%
Return on average assets 6.87% 6.68%
Return on average equity 13.09% 12.17%
Employees 130,000 -
CDP Score - 92 B


One CVS Drive
United States - Map
+1-401-7651500 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha
About Company - Wikipedia


CVS Caremark Corporation (CVS Caremark), together with its subsidiaries, is a pharmacy health care provider in the United States. CVS Caremark provides pharmacy services through its pharmacy benefit management (PBM), mail order and specialty pharmacy division, CVS Caremark Pharmacy Services; approximately 7,300 CVS/pharmacy retail stores; retail-based health clinic subsidiary, MinuteClinic, and its online retail pharmacy, The Company operates in three business segments: Pharmacy Services, Retail Pharmacy and Corporate. Its corporate segment provides management and administrative services. The Corporate segment consists of certain aspects of its executive management, corporate relations, legal, compliance, human resources, corporate information technology and finance departments. In January 2014, Cvs Caremark Corporation completed the acquisition of Coram LLC, the specialty infusion services and enteral nutrition business unit of Apria Healthcare Group Inc.

Officers and directors

David W. Dorman Independent Chairman of the Board
Age: 60
Bio & Compensation  - Reuters
Larry J. Merlo President, Chief Executive Officer, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
David M. Denton Chief Financial Officer, Executive Vice President
Age: 48
Bio & Compensation  - Reuters
Lisa G. Bisaccia Chief Human Resource Officer, Senior Vice President
Age: 57
Bio & Compensation  - Reuters
Thomas M. Moriarty Executive Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Troyen A. Brennan M.D. Executive Vice President, Chief Medical Officer
Age: 59
Bio & Compensation  - Reuters
Helena B. Foulkes Executive Vice President, President of CVS/pharmacy
Age: 49
Bio & Compensation  - Reuters
J. David Joyner Executive Vice President
Age: 49
Bio & Compensation  - Reuters
Per G. H. Lofberg Executive Vice President
Age: 66
Bio & Compensation  - Reuters
Jonathan C. Roberts Executive Vice President; President of CVS Caremark Pharmacy Services
Age: 58
Bio & Compensation  - Reuters